Chemoprevention of esophageal squamous cell carcinoma

Toxicology and Applied Pharmacology

Volumn 224, Issue 3, 2007, Pages 337-349

  Stoner, Gary D ^a   Wang, Li Shu ^a   Chen, Tong ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Chemoprevention; Esophagus; Human; Rat; Squamous cell carcinoma

Indexed keywords

ALLYL SULFIDE; ANTINEOPLASTIC AGENT; CATECHIN; CELECOXIB; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; DIETHYLNITROSAMINE; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; HERBACEOUS AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOTHIOCYANIC ACID; L 748706; N BENZYL N METHYLNITROSAMINE; N METHYL N PENTYLNITROSAMINE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENETHYL ISOTHIOCYANATE; PHENYLBUTYLISOTHIOCYANATE; PHENYLETHYLISOTHIOCYANATE; PHENYLPROPYLISOTHIOCYANATE; PIROXICAM; PLANT EXTRACT; RESVERATROL; RETINOID; SELENOMETHIONINE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; THEAFLAVIN; TILMACOXIB; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BERRY; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CHEMOPROPHYLAXIS; CHINA; CLINICAL TRIAL; DISEASE COURSE; DNA DAMAGE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS DISEASE; FREEZE DRYING; HUMAN; NONHUMAN; PRECANCER; REVIEW;

ALLYL COMPOUNDS; ANIMALS; CARCINOMA, SQUAMOUS CELL; CHEMOPREVENTION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FLAVONOIDS; HUMANS; ISOTHIOCYANATES; MOLECULAR STRUCTURE; PHENOLS; SULFIDES;

RATTUS;

EID: 35348883867     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.01.030     Document Type: Review

References (123)

1. An J.Y., Fan Z.M., Gao S.S., Zhuang Z.H., Qin Y.R., Li J.L., He X., Tsao G.S., and Wang L.D. Loss of heterozygosity in multistage carcinogenesis of esophageal carcinoma at high-incidence area in Henan Province, China. World J. Gastroenterol. 11 (2005) 2055-2060
2. Anani P.A., Gardiol D., Savary M., and Monnier P. An extensive morphological and comparative study of clinically early and obvious squamous cell carcinoma of the esophagus. Pathol. Res. Pract. 187 (1991) 214-219
3. Ando T., Ishiguro H., Kimura M., Mitsui A., Kurehara H., Sugito N., Tomoda K., Mori R., Takashima N., Ogawa R., Fujii Y., and Kuwabara Y. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis. Esophagus 19 (2006) 454-458
4. Anupam K., Tusharkant C., Gupta S.D., and Ranju R. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J. Gastroenterol. 12 (2006) 6041-6045
5. Asamoto M., Toriyama-Baba H., Ohnishi T., Naito A., Ota T., Ando A., Ochiya T., and Tsuda H. Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis. Jpn. J. Cancer Res. 93 (2002) 744-751
6. Barch D.H., and Fox C.C. Dietary ellagic acid reduces the esophageal microsomal metabolism of methylbenzylnitrosamine. Cancer Lett. 44 (1989) 39-44
7. Beer D.G., and Stoner G.D. Clinical models of chemoprevention for the esophagus. Hematol. Oncol. Clin. North Am. 12 (1998) 1055-1077
8. Brady J.F., Li D.C., Ishizaki H., and Yang C.S. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Cancer Res. 48 (1988) 5937-5940
9. Carlson D.G., Daxenbichler M.E., VanEtten C.H., Tookey M.L., and Williams P.H. Glucosinolates in crucifer vegetables: turnips and rutabagas. J. Agric. Food Chem. 29 (1981) 1235-1241
10. Carlton P.S., Kresty L.A., Siglin J.C., Morse M.A., Lu J., Morgan C., and Stoner G.D. Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis 22 (2001) 441-446
11. Carlton P.S., Gopalakrishnan R., Gupta A., Liston B.W., Habib S., Morse M.A., and Stoner G.D. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus. Cancer Res. 62 (2002) 4376-4382
12. Chang M.S., Lee H.S., Lee B.L., Kim Y.T., Lee J.S., and Kim W.H. Differential protein expression between esophageal squamous cell carcinoma and dysplasia, and prognostic significance of protein markers. Pathol. Res. Pract. 201 (2005) 417-425
13. Chen T., and Stoner G.D. Inducible nitric oxide synthase expression in N-nitrosomethylbenzylamine (NMBA)-induced rat esophageal tumorigenesis. Mol. Carcinog. 40 (2004) 232-240
14. Chen T., Nines R.G., Peschke S.M., Kresty L.A., and Stoner G.D. Chemopreventive effects of a selective nitric oxide synthase inhibitor on carcinogen-induced rat esophageal tumorigenesis. Cancer Res. 64 (2004) 3714-3717
15. Chen T., Hwang H., Rose M.E., Nines R.G., and Stoner G.D. Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun. Cancer Res. 66 (2006) 2853-2859
16. Chen T., Rose M.E., Hwang H., Nines R.G., and Stoner G.D. Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS. Carcinogenesis 27 (2006) 2301-2307
17. Corley D.A., Kerlikowske K., Verma R., and Buffler P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124 (2003) 47-56
18. Daniel E.M., and Stoner G.D. The effects of ellagic acid and 13-cis-retinoic-acid on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats. Cancer Lett. 56 (1991) 117-124
19. Daniel E.M., Krupnick A.S., Heur Y.H., Blinzler J.A., Nims R.W., and Stoner G.D. Extraction, stability and quantitation of ellagic acid in various fruits and nuts. J. Food Compos. Anal. 2 (1989) 338-349
20. de Boer J.G., Yang H., Holcroft J., and Skov K. Chemoprotection against N-nitrosomethylbenzylamine-induced mutation in the rat esophagus. Nutr. Cancer 50 (2004) 168-173
21. Freeman H.J. Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment. Best Pract. Res. Clin. Gastroenterol. 18 (2004) 1167-1175
22. Fujiwara Y., Osugi H., Morimura K., Takemura M., Lee S., Hirohashi K., Fukushima S., and Suehiro S. Suppressive effect of CPT-11 on rat esophageal tumorigenesis induced by N-nitrosomethylbenzylamine. Oncol. Rep. 12 (2004) 1169-1176
23. Gao H., Wang L.D., Zhou Q., Hong J.Y., Huang T.Y., and Yang C.S. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res. 54 (1994) 4342-4346
24. Gotoh T., Yamada K., Yin H., Ito A., Kataoka T., and Dohi K. Chemoprevention of N-methyl-N-nitrosourea induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn. J. Cancer Res. 89 (1998) 137-142
25. Guo Y.J., Lu H., Liang Y.Y., He L.Z., and Wang H. Amplification of int-2 gene in primary esophageal carcinoma and fetal esophageal carcinoma induced by N-methyl-N-benzylnitrosamine. Chin. J. Oncol. 15 (1993) 91-93
26. Gupta A., Nines R., Rodrigo K.A., Aziz R.A., Carlton P.S., Gray D.L., Steele V.E., Morse M.A., and Stoner G.D. Effects of dietary N-(4-hydroxyphenyl)retinamide on N-nitrosomethylbenzylamine metabolism and esophageal tumorigenesis in the Fischer 344 rat. J. Natl. Cancer Inst. 93 (2001) 990-998
27. Hanley A.B., Heaney R.K., and Fenwick G.R. Improved isolation of glucobrassicin and other glucosinolates. J. Sci. Food Agric. 34 (1983) 869-874
28. Hecht S.S., and Stoner G.D. Lung and esophageal carcinogenesis. In: Aisner J., Arriagada R., Green M.R., Martini N., and Perry M.C. (Eds). Comprehensive Textbook of Thoracic Oncology (1996), Williams and Wilkins, Baltimore, MD 25-50
29. Hiyama T., Yokozaki H., Kitadai Y., Haruma K., Yasui W., Kajiyama G., and Tahara E. Overexpression of human telomerase RNA is an early event in esophageal carcinogenesis. Virchows Arch. 434 (1999) 483-487
30. Hollstein M., Smits A.M., Galiana C., Yamasaki H., Bos J.L., Mandard A., Partensky C., and Montesano R. Amplification of EGF receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res. 48 (1988) 5119-5123
31. Hollstein M., Peri L., Mandard A.M., Welsh J.A., Montesano R., Metcalf R.A., Bak M., and Harris C.C. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res. 51 (1991) 4102-4106
32. Hu G., Han C., Wild C.P., Hall J., and Chen J. Lack of effects of selenium on N-nitrosomethylbenzylamine-induced tumorigenesis, DNA methylation and oncogene expression in rats and mice. Nutr. Cancer 18 (1992) 287-295
33. Hudson T.S., Carlton P.S., Gupta A., Stoner G.D., and Morse M.A. Investigation of the enhancement of NMBA-induced esophageal tumorigenesis by 6-phenylhexyl isothiocyanate. Cancer Lett. 162 (2001) 19-26
34. Hughes J.S., Ganthavorn C., and Wilson-Sanders S. Dry beans inhibit azoxymethane-induced colon carcinogenesis in F344 rats. J. Nutr. 127 (1997) 2328-2333
35. Ishikawa A., Kuriyama S., Tsubono Y., Fukao A., Takahashi H., Tachiya H., and Tsuji I. Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men. J. Epidemiol. 16 (2006) 185-192
36. Jiang W., Zhang Y.J., Kahn M.C., Hollstein R.M., Santella S.H., Lu S.H., Harris C.C., and Montesano R. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9026-9030
37. Khare L., Sabourin C.L.K., Young B.R.D., Jamasbi R.J., and Stoner G.D. Altered localization of E-cadherin and alpha-catenin in rat esophageal tumors. Int. J. Oncol. 14 (1999) 33-40
38. Kimura Y., Shiozaki H., Doki Y., Yamamoto M., Utsunomiya T., Kawanishi K., Fukuchi N., Inoue M., Tsujinaka T., and Monden M. Cytoplasmic β-catenin in esophageal cancers. Int. J. Cancer Pred. Oncol. 84 (1999) 174-178
39. Krasna M.J., and Wolfer R.S. Esophageal carcinoma: diagnosis, evaluation and staging. In: Aisner J., Arriagada R., Green M.R., Martini N., and Perry M.C. (Eds). Comprehensive Textbook of Thoracic Oncology (1996), Williams and Wilkins, Baltimore, MD 563-584
40. Kresty L.A., Morse M.A., Morgan C., Carlton P.S., Lu J., Gupta A., Blackwood M., and Stoner G.D. Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res. 61 (2001) 6112-6119
41. Kuno T., Hirose Y., Hata K., Kato K., Qiang S.H., Kitaori N., Hara A., Iwasaki T., Yoshimura T., Wada K., Kobayashi H., and Mori H. Preventive effect of fermented brown rice and rice bran on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats. Int. J. Oncol. 25 (2004) 1809-1815
42. Kuroki T., Trapasso F., Yendamuri S., Matsuyama A., Alder H., Mori M., and Croce C.M. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 63 (2003) 3724-3728
43. Kuwano H., Watanabe M., Sadanaga N., Ikebe M., Mori M., and Sugimachi K. Squamous epithelial dysplasia associated with squamous cell carcinoma of the esophagus. Cancer Lett. 72 (1993) 141-147
44. Lam A.K.Y. Molecular biology of esophageal squamous cell carcinoma. Crit. Rev. Oncol. Hematol. 33 (2000) 71-90
45. Layke J.C., and Lopez P.P. Esophageal cancer: a review and update. Am. Fam. Phys. 73 (2006) 2187-2194
46. Li M.N., and Cheng S.J. Etiology of carcinoma of the esophagus. In: Huang G.J., and Kai W.Y. (Eds). Carcinoma of the Esophagus and Gastric Cardia (1984), Springer-Verlag, Berlin, Germany 26-51
47. Li M.H., Ji C., and Cheng S.J. Occurrence of nitroso compounds in fungi-contaminated foods: a review. Nutr. Cancer 8 (1986) 63-69
48. Li Z.G., Shimada Y., Kawabe A., Sato F., Maeda M., Komoto I., Hong T., Ding Y., Kaganoi J., and Imamura M. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor. Carcinogenesis 22 (2001) 547-551
49. Li Z.G., Hong T., Shimada Y., Komoto I., Kawabe A., Ding Y., Kaganoi J., Hashimoto Y., and Imamura M. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 23 (2002) 1531-1536
50. Li Z.G., Shimada Y., Sato F., Maeda M., Itami A., Kaganoi J., Komoto I., Kawabe A., and Imamura M. Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats. Int. J. Oncol. 21 (2002) 1275-1283
51. Limburg P.J., Wei W., Ahnen D.J., Qiao Y., Hawk E.T., Wang G., Giffen C.A., Wang G., Roth M.J., Lu N., Korn E.L., Ma Y., Caldwell K.L., Dong Z., Taylor P.R., and Dawsey S.M. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 129 (2005) 863-873
52. Lin P., Zhang J., Rong Z., Han R., Xu S., Gao R., Ding Z., Wang J., Feng H., and Cao S. Studies on medicamentous inhibitory therapy for esophageal precancerous lesions-3- and 5-year inhibitory effects of antitumor-B, retinamide and riboflavin. Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll. 5 (1990) 121-129
53. Liston B.W., Gupta A., Nines R., Carlton P.S., Kresty L.A., Harris G.K., and Stoner G.D. Incidence and effects of Ha-ras codon 12 G → A transition mutations in preneoplastic lesions induced by N-nitrosomethylbenzylamine (NMBA) in the rat esophagus. Mol. Carcinog. 32 (2001) 1-8
54. Liston B.W., Nines R., Carlton P.S., Gupta A., Aziz R., Frankel W., and Stoner G.D. Perillyl alcohol as a chemopreventive agent in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Cancer Res. 63 (2003) 2399-2403
55. Lozano J.C., Nakazawa H., Cros M.P., Cabral R., and Yamasaki H. G to A mutations in p53 and Ha-ras genes in esophageal papillomas induced by N-nitrosomethylbenzylamine in two strains of rats. Mol. Carcinog. 9 (1994) 33-39
56. Lu S.H., Hsieh L.L., Luo F.C., and Weinstein I.B. Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int. J. Cancer 42 (1988) 502-505
57. Lu S.H., Chui S.X., Yang W.X., Hu X.N., Guo L.P., and Li F.M. Relevance of N-nitrosamines to esophageal cancer in China. In: O'Neill I.K., Chen J., and Bartsch H. (Eds). Relevance to Human Cancer of N-nitroso Compounds, Tobacco Smoke and Mycotoxin. IARC Scientific Publications vol. 105 (1991), IARC, Lyon 11-17
58. Mandal S., and Stoner G.D. Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 11 (1990) 55-61
59. Mandal S., Shivapurkar N.M., Galati A.J., and Stoner G.D. Inhibition of N-nitrosomethylbenzylamine metabolism and DNA binding in cultured rat esophagus by ellagic acid. Carcinogenesis 9 (1988) 1313-1316
60. Mandard A.M., Hainaut P., and Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat. Res. 462 (2000) 335-342
61. Melendez-Martinez A.J., Vicario I.M., and Heredia F.J. Nutritional importance of carotenoid pigments. Arch. Latinoam Nutr. 54 (2004) 149-154
62. Moodley R., Reddi A., Chetty R., and Naidoo R. Abnormalities of chromosome 17 in oesophageal cancer. J. Clin. Pathol. (2006) (Epub ahead of print)
63. Mori Y., Tatematsu K., Koide A., Sugie S., Tanaka T., and Mori H. Modification by curcumin of mutagenic activation of carcinogenic N-nitrosamines by extrahepatic cytochromes P-450 2B1 and 2E1 in rats. Cancer Sci. 97 (2006) 896-904
64. Morse M.A., Eklind K.I., Hecht S.S., Jordan K.G., Choi C.I., Desai D.H., Amin S.G., and Chung F.L. Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice. Cancer Res. 51 (1991) 1846-1850
65. Morse M.A., Kresty L.A., Steele V.E., Kelloff G.J., Boone C.W., Balentine D.A., Harbowy M.E., and Stoner G.D. Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis. Nutr. Cancer 29 (1997) 7-12
66. Morse M.A., Lu J., Gopalakrishnan R., Peterson L.A., Wani G., and Stoner G.D. Mechanism of enhancement of esophageal tumorigenesis by 6-phenylhexyl isothiocyanate. Cancer Lett. 112 (1997) 119-125
67. Munoz N., and Buiatti E. Chemoprevention of oesophageal cancer. IARC Sci. Publ. 136 (1996) 27-33
68. Munoz N., Lipkin M., Crespi M., Wahrendorf J., Grassi A., and Lu S.H. Proliferative abnormalities of the esophageal epithelium in Chinese populations at high and low risk for esophageal cancer. Int. J. Cancer 36 (1985) 187-189
69. Narisawa T., Fukaura Y., Hasebe M., Nomura S., Oshima S., Sakamoto H., and Inakuma T. Prevention of N-methylnitrosourea-induced colon carcinogenesis in rats by oxygenated carotenoid capsanthin and capsanthin-rich paprika juice. Proc. Soc. Exp. Biol. Med. 224 (2000) 116-122
70. Okajima E., Tsutsumi M., Ozono S., Akai H., Denda A., Nishino H., Oshima S., Sakamoto H., and Konishi Y. Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroxybutyl)nitrosamine initiation. Jpn. J. Cancer Res. 89 (1988) 22-26
71. Parkin D.M., Bray F.I., and Devesa S.S. Cancer burden in the year 2000. The global picture. Eur. J. Cancer 37 (2001) S4-S66
72. Pickens A., and Orringer M.B. Geographical distribution and racial disparity in esophageal cancer. Ann. Thorac. Surg. 76 (2003) S1367-S1369
73. Polednak A.P. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int. J. Cancer 105 (2003) 98-100
74. Raida M., Sarbia M., Clement J.H., Adam S., Gabbert H.E., and Hoeffken K. Expression, regulation and clinical significance of bone morphogenic protein 6 in esophageal squamous-cell carcinoma. Int. J. Cancer 83 (1999) 38-44
75. Rao M., Liu F.S., Dawsey S.M., Yang K., Lipkin M., Li J.Y., Taylor P.R., Li B., Blot W.J., Wang G.Q., Lewin K.J., Yu Y., and Yang C.S. Effects of vitamin/mineral supplementation on the proliferation of esophageal squamous epithelium in Linxian, China. Cancer Epidemiol. Biomark. Prev. 3 (1994) 277-279
76. Reen R.K., Nines R., and Stoner G.D. Modulation of N-nitrosomethylbenzylamine metabolism by black raspberries in the esophagus and liver of Fischer 344 rats. Nutr. Cancer. 54 (2006) 47-57
77. Ribeiro Jr.U., Posner M.C., Safatle-Ribeiro A.V., and Reynolds J.C. Risk factors for squamous cell carcinoma of the esophagus. Br. J. Surg. 83 (1996) 1174-1185
78. Rijken P.J., Timmer W.G., van de Kooij A.J., van Benschop I.M., Wiseman S.A., Meijers M., and Tijburg L.B.M. Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats. Carcinogenesis 20 (1999) 2267-2272
79. Rose E. Esophageal cancer in Transkei: 1955-69. J. Natl Cancer Inst. 51 (1973) 7-16
80. Schaffer E.M., Liu J.Z., Green J., Dangler C.A., and Milner J.A. Garlic and associated allyl sulfur compounds inhibit N-methyl-N-nitrosourea induced rat mammary carcinogenesis. Cancer Lett. 102 (1996) 199-204
81. Schottenfeld D. Epidemiology of cancer of the esophagus. Semin. Oncol. 11 (1984) 92-100
82. Shu Y.J., Uan X.Q., and Jin S.P. Further investigation of the relationship between dysplasia and cancer of the esophagus. Chin. Med. 6 (1981) 39-41
83. Siglin J.C., Barch D.H., and Stoner G.D. Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Carcinogenesis 16 (1995) 1101-1106
84. Sons H.U. Etiologic and epidemiologic factors of carcinoma of the esophagus. Surg. Gynecol. Obstet. 165 (1987) 183-190
85. Souza R.F. Molecular and biologic basis of upper gastrointestinal malignancy-esophageal carcinoma. Surg. Oncol. Clin. N. Am. 11 (2002) 257-272
86. Stoner G.D., and Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22 (2001) 1737-1746
87. Stoner G.D., and Morse M.A. Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett. 114 (1997) 113-119
88. Stoner G.D., Morrissey D.T., Heur Y.H., Daniel E.M., Galati A.J., and Wagner S.A. Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus. Cancer Res. 51 (1991) 2063-2068
89. Stoner G.D., Siglin J.C., Morse M.A., Desai D.H., Amin S.G., Kresty L.A., Toburen A.L., Heffner E.M., and Francis D.J. Enhancement of esophageal carcinogenesis in male F344 rats by dietary phenylhexyl isothiocyanate. Carcinogenesis 16 (1995) 2473-2476
90. Stoner G.D., Adams C., Kresty L.A., Amin S.G., Desai D., Hecht S.S., Murphy S.E., and Morse M.A. Inhibition of N′-nitrosonornicotine-induced esophageal tumorigenesis by 3-phenylpropyl isothiocyanate. Carcinogenesis 19 (1998) 2139-2143
91. Stoner G.D., Kresty L.A., Carlton P.S., Siglin J.C., and Morse M.A. Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancer. Toxicol. Sci. 52S (1999) 95-100
92. Stoner G.D., Qin H., Chen T., Carlton P.S., Rose M.E., Aziz R.M., and Dixit R. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis 26 (2005) 1590-1595
93. Stoner G.D., Sardo C., Apseloff G., Mullet D., Wargo W., Pound V., Singh A., Sanders J., Aziz R., Casto B., and Sun X. Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days. J. Clin. Pharmacol. 45 (2005) 1153-1164
94. Stoner G.D., Chen T., Kresty L.A., Aziz R.M., Reinemann T., and Nines R. Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms. Nutr. Cancer. 54 (2006) 33-46
95. Tanaka H., Kijima H., Tokunaga T., Tajima T., Himeno S., Kenmochi T., Oshiba G., Kise Y., Nishi T., Chino O., Shimada H., Machimura T., Tanaka M., and Makuuchi H. Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas. Int. J. Oncol. 14 (1999) 1069-1073
96. Togawa K., Jaskiewicz K., Takahashi H., Meltzer S.J., and Rustigi A.K. Human papillomavirus DNA sequences in esophageal squamous cell carcinoma. Gastroenterology 107 (1994) 128-136
97. Tuyns A.J. Recherches concernant les facteurs etiologiques du cancer de l'oesophage dans l'ouest de la France. Bull. Cancer. 67 (1980) 15-28
98. Tuyns A.J. Epidemiology of esophageal cancer in France. In: Pfeifer C.J. (Ed). Cancer of the Esophagus (1982), CRC Press, Boca Raton, FL 3-22
99. 6-methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int. J. Cancer 36 (1985) 661-665
100. Ushida J., Sugie S., Kawabata K., Pham Q.V., Tanaka T., Fujii K., Takeuchi H., Ito Y., and Mori H. Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn. J. Cancer Res. 91 (2000) 893-898
101. Wang L.D., Lipkin M., Qui S.L., Yang G.R., Yang C.S., and Newmark H.L. Labeling index and labeling distribution of cells in esophageal epithelium of individuals at increased risk for esophageal cancer in Huixian, China. Cancer Res. 50 (1990) 2651-2653
102. Wang Y., You M., Reynolds S.H., Stoner G.D., and Anderson M.W. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res. 50 (1990) 1591-1595
103. Wang L.D., Qiu S.L., Yang G.R., Lipkin M., Newmark H.L., and Yang C.S. A randomized double blind intervention study on the effect of calcium supplementation on esophageal precancerous lesions in a high-risk population in China. Cancer Epidemiol. Biomark. Prev. 2 (1993) 71-78
104. Wang Z.Y., Wang L.D., Lee M.J., Ho C.T., Huang M.T., Conney A.H., and Yang C.S. Inhibition of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in rats by green tea and black tea. Carcinogenesis 16 (1995) 2143-2148
105. Wang D., Weghorst C.M., Calvert R.J., and Stoner G.D. Mutations in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine. Carcinogenesis 17 (1996) 625-630
106. Wang Q.S., Sabourin C.L.K., Kresty L.A., and Stoner G.D. Dysregulation of transforming growth factor β1 expression in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Int. J. Oncol. 9 (1996) 473-479
107. Wang Q.S., Sabourin C.L.K., Wang H., and Stoner G.D. Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis 17 (1996) 1583-1588
108. Wang L.D., Zhou Q., Feng C.W., Liu B., Qi Y.J., Zhang Y.R., Gao S.S., Fan Z.M., Zhou Y., Yang C.S., Wei J.P., and Zheng S. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Gan To Kagaku Ryoho 29 (2002) 159-172
109. Wang G.Q., Abnet C.C., Shen Q., Lewin K.J., Sun X.D., Roth M.J., Qiao Y.L., Mark S.D., Dong Z.W., Taylor P.R., and Dawsey S.M. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 54 (2005) 187-192
110. Wargovich M.J., Woods C., Eng V.W.S., Stephens L.C., and Gray K. Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by naturally-occurring thioether, diallyl sulfide. Cancer Res. 48 (1988) 6872-6875
111. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45 (1985) 1-8
112. Wilkinson J.T., Morse M.A., Kresty L.A., and Stoner G.D. Effect of alkyl chain length on inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis and DNA methylation by isothiocyanates. Carcinogenesis 16 (1995) 1011-1015
113. Wynder E.L., and Bross I.J. A study of etiological factors in cancer of the esophagus. Cancer 14 (1961) 389-401
114. INK5b are frequent events in human esophageal cancer in Linxian, China. Carcinogenesis 20 (1999) 77-84
115. Xu X.C., Liu X., Tahara E., Lippman S.M., and Lotan R. Expression and up-regulation of retinoic acid receptor-β is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 59 (1999) 2477-2483
116. Xu X.C., Lee J.J., Wu T.T., Hoque A., Ajani J.A., and Lippman S.M. Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinoma. Cancer Epidemiol. Biomark. Prev. 14 (2005) 826-829
117. Yang C.S. Research on esophageal cancer in China: a review. Cancer Res. 40 (1980) 2633-2640
118. Yang W.X., Pu J., Lu S.H., Li F.M., and Guo L.P. Studies on the exposure level of nitrosamines in the gastric juice and its inhibition in high risk areas of esophageal cancer. Chin. J. Oncol. 14 (1992) 407-410
119. Yang G.Z., Li L., Ding H.Y., and Zhou J.S. Cyclooxygenase-2 is over-expressed in Chinese esophageal squamous cell carcinoma, and correlated with NF-kappaB: an immunohistochemical study. Exp. Mol. Pathol. 79 (2005) 214-218
120. Younes M., Henson D.E., Ertan A., and Miller C.C. Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand. J. Gastroenterol. 37 (2002) 1359-1365
121. Youssef E.M., Hasuma T., Morishima Y., Takada N., Osugi H., Higashino M., Otani S., and Fukushima S. Overexpression of cyclin D1 in rat esophageal carcinogenesis model. Jpn. J. Cancer Res. 88 (1997) 18-25
122. Yu H.P., Liu L., Shi L.Y., Lu W.H., and Xu S.Q. Expression of cyclooxygenase-2 in esophageal squamous cell carcinogenesis. Zhonghua Yu Fang Yi Xue Za Zhi 38 (2004) 22-25
123. Zimmermann K.C., Sarbia M., Weber A.A., Borchard F., Gabbert H.E., and Schroer K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59 (1999) 198-204